1. Catalog
  2. CSHP2503 - CME/CMLE - TP53-Negative (Wild-type) Ac ...
Image For Activity Cover
CSHP2503 - CME/CMLE - TP53-Negative (Wild-type) Acute/Pure Erythroid Leukemia and Erythroid Sarcoma
Course Description

Faculty/Authors

Jason X. Cheng, MD, PhD 
Peng Wang, MD, PhD 
Sandeep Gurbuxani, MD, PhD 
Girish Venkataraman, MD 
Angela Lager, PhD 
Daniel A. Arber, MD
Department of Pathology
University of Chicago 

Chicago, Illinois 

CME or CMLE Credit: 2.0
Estimated Completion Time: 2 hours
Format: Online Educational Activity and Post Exam

Physician Competencies: Patient Care, Medical Knowledge

Eligibility for CME/CMLE credit: Max three attempts. You will have a maximum of three attempts to meet the following criteria:

  • Module ≥80% = CME credit
  • Module <80% = No CME credit, after a maximum of three attempts

Default Credit Type: None (You must meet the eligibility requirements in order to obtain CME credit.)

Accreditation Statement: The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME).

Credit Designation Statement: The American Society for Clinical Pathology (ASCP) designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions

  1. Review the Technical Considerations.
  2. Click Go to Course to view an overview of the modules in this course.
  3. Click Access to begin the course.
  4. Choose the CME Activity to earn CME credit or the CMLE Activity to earn CMLE credit.

To claim CME credit for the exercise, do the following:

  1. Review the Educational Activity.
  2. Complete and submit the Post Exam. You will have a maximum of three attempts to obtain the required score. You will be notified if you have met the credit requirements after each attempt.
  3. Submit the course Evaluation.
  4. Enter the maximum number of credits offered and click Claim CME to register credit.

To claim CMLE credit for the exercise, do the following:

  1. Review the Educational Activity.
  2. Complete and submit the Post Exam.
  3. Submit the course Evaluation.
  4. Enter the maximum number of credits offered and click Claim CME to register credit.

Faculty Disclosures

Technical Considerations

Release Date: 6/30/2025     
Review Date:
Expiration Date: 12/31/2027   

Learning Objectives
Upon completion of this activity, you will be able to:

  • know about the history and the evolving classification of AEL/PEL; 

  • understand the difference in the AEL/PEL classification between the current 5th edition WHO and the 2022 ICC classifications; 

  • recognize the distinct clinicopathologic features of TP53- and TP53+ AEL/PEL and ES as well as benign erythroid proliferation/hyperplasia; 

  • be familiar with the difficulties and pitfalls in diagnosis of TP53- AEL/PEL and ES as well as their associated typical genetic alterations; and 

  • know how to conduct appropriate morphological, immunophenotypic, molecular and genetic studies for differential diagnosis of TP53- and TP53+ ES and AEL/PEL and other mimics. 

Summary
Availability:
On-Demand
Credit Offered:
2 CME Credits
2 CMLE Credits
Powered By